216 related articles for article (PubMed ID: 8336397)
1. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
[TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
[TBL] [Abstract][Full Text] [Related]
4. [Urinary cross-linked FDP in various renal diseases].
Inuma H
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
[TBL] [Abstract][Full Text] [Related]
5. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
Shibata K; Dohi K; Fujii Y; Ishikawa H
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
[TBL] [Abstract][Full Text] [Related]
6. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
7. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
8. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
[TBL] [Abstract][Full Text] [Related]
9. Role of intrarenal coagulation and anticoagulant therapy in the progression of diabetic nephropathy.
Kaizu K; Uriu K; Hashimoto O; Morita E; Eto S; Suzuki H
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):35-42. PubMed ID: 8336398
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
11. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting].
Okumura N; Kagiya H; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047
[TBL] [Abstract][Full Text] [Related]
12. [FDP-E--quantitative analysis by LPIA (latex photometric immunoassay) method].
Furusaki F; Sudo T; Tsutsui S
Rinsho Byori; 1989 Apr; Spec No 81():168-75. PubMed ID: 2754804
[No Abstract] [Full Text] [Related]
13. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
Wilson JE; Thornton RD
Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
[TBL] [Abstract][Full Text] [Related]
14. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
Horiuchi N; Aoki Y; Terada H
Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
[No Abstract] [Full Text] [Related]
16. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulation.
Loschiavo C; Previato G; Valvo E; Lupo A; Tessitore N; Chiaramonte S; Maschio G
Nephron; 1981; 28(4):200-3. PubMed ID: 7029322
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen degradation products in acute renal failure of the newborn.
Assadi F; Delivoria-Papadopoulos M; Pereira G; Peckham G; Norman M
Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
